![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1307, 2001-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemifloxacin offers advantages over clarithromycin for AECB
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 331, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemifloxacin offers advantages in the treatment of acute exacerbations of chronic bronchitis
Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Gemifloxacin and levofloxacin have similar efficacy in AECB
Inpharma, Vol. 1, Iss. 1461, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Drugs, Vol. 59, Iss. 5, 2000-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Buprenorphine offers no significant advantage over methadone
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :